Journals / Kulak Burun Boğaz Uygulamaları / 2020 / Cilt: 8 - Sayı: 1

Do blood groups have any effect on prognosis of sudden sensorineural hearing loss?

Ani sensörinöral işitme kaybı prognozunda kan gruplarının etkisi var mıdır?

Pages
41–46
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Pre- and post-treatmentaudiometric examination of patients did not show any significantdifference in terms of hearing thresholds (p>0.05).Conclusion: According to our findings, ABO blood groupsystem does not affect the distribution and prognosis of ISSNHL

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: This study aims to investigate the effects of ABOblood groups on prognosis and distribution of disease inidiopathic sudden sensorineural hearing loss (ISSNHL) as ahematological and vascular parameter.Patients and Methods: Medical records of 78 patients(44 males, 34 females; mean age 45.6 years; range, 14 to 80years) treated for ISSNHL in our clinic between January 2008and June 2019 were retrospectively analyzed.
📊
Key Findings & Data:Patients wereseparated as A, B, AB and O groups regardless of their Rhfactors.
💡
Conclusion & Impact:Pre- and post-treatmentaudiometric examination of patients did not show any significantdifference in terms of hearing thresholds (p>0.05).Conclusion: According to our findings, ABO blood groupsystem does not affect the distribution and prognosis of ISSNHL
🔬Design:Research Article
📍Scope:2019 Verileri
⚙️Variables:Domain Parameters

Abstract

Objectives: This study aims to investigate the effects of ABOblood groups on prognosis and distribution of disease inidiopathic sudden sensorineural hearing loss (ISSNHL) as ahematological and vascular parameter.Patients and Methods: Medical records of 78 patients(44 males, 34 females; mean age 45.6 years; range, 14 to 80years) treated for ISSNHL in our clinic between January 2008and June 2019 were retrospectively analyzed. Patients wereseparated as A, B, AB and O groups regardless of their Rhfactors. Distribution of ISSNHL was examined in the groups.Hearing gain after treatment was compared according topatients’ blood groups in terms of prognosis.Results: There were 32 group A (41%), 13 group B (16.7%),four group AB (5.1%) and 29 group O (37.2%) patients. Nosignificant difference was observed when the blood groupdistribution of patients was compared to the local ABOblood group distribution in Istanbul city (p>0.05). There wasno significant difference between patients’ age and genderdistribution (p>0.05). The measurements of hearing thresholdsat 250 Hz, 500 Hz, 1000 Hz, 2000 Hz, 4000 Hz and 8000 Hzfrequencies were significantly lower after treatment (p0.05). Pre- and post-treatmentaudiometric examination of patients did not show any significantdifference in terms of hearing thresholds (p>0.05).Conclusion: According to our findings, ABO blood groupsystem does not affect the distribution and prognosis of ISSNHL

Özet

Amaç: Bu çalışmada idiyopatik ani sensörinöral işitme kaybında (İASNİK) ABO kan gruplarının hematolojik ve vasküler bir parametre olarak hastalığın prognozu ve dağılımı üzerindeki etkisi araştırıldı. Hastalar ve Yöntemler: Kliniğimizde Ocak 2008 ve Haziran 2019 tarihleri arasında İASNİK nedeniyle tedavi edilen 78 hastanın (44 erkek, 34 kadın; ort. yaş 45.6 yıl; dağılım, 14-80 yıl) tıbbi kayıtları retrospektif olarak incelendi. Hastalar Rh faktörlerine bakılmaksızın A, B, AB ve O grubu olarak ayrıldı. İdiyopatik ani sensörinöral işitme kaybının gruplardaki dağılımı incelendi. Tedavi sonrası işitme kazanımı hastaların kan gruplarına göre prognoz açısından karşılaştırıldı. Bulgular: Otuz iki grup A (%41), 13 grup B (%16.7), dört grup AB (%5.1) ve 29 grup O (%37.2) hasta vardı. Hastaların kan grubu dağılımı İstanbul ilindeki yerel ABO kan grubu dağılımı ile karşılaştırıldığında anlamlı farklılık gözlemlenmedi (p>0.05). Hastaların yaş ve cinsiyet dağılımı arasında anlamlı farklılık yoktu (p>0.05). İşitme eşiklerinin 250 Hz, 500 Hz, 1000 Hz, 2000 Hz, 4000 Hz ve 8000 Hz frekanslarındaki ölçümleri tedavi sonrasında anlamlı olarak daha düşüktü (p0.05). Hastaların tedavi öncesi ve sonrası odyometrik muayenesi işitme eşikleri açısından anlamlı farklılık göstermedi (p>0.05). Sonuç: Bulgularımıza göre, ABO kan grubu sistemi İASNİK’nin dağılımını ya da prognozunu etkilememektedir.

🔖

Cite This Article

KIRGEZEN, T., YİĞİT, Ö., SEDEN, N., MİSİR, E. (2022). Do blood groups have any effect on prognosis of sudden sensorineural hearing loss?. Kulak Burun Boğaz Uygulamaları, Cilt: 8 - Sayı: 1, 41–46. https://ajindex.com/articles/576527

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Psifidis AD, Psillas GK, Daniilidis JCh. Sudden sensorineural hearing loss: long-term follow-up results. Otolaryngol Head Neck Surg 2006;134:809-15
  2. Chao TK, Chen TH. Distortion product otoacoustic emissions as a prognostic factor for idiopathic sudden sensorineural hearing loss. Audiol Neurootol 2006;11:331-8
  3. Penido Nde O, Ramos HV, Barros FA, Cruz OL, Toledo RN. Clinical, etiological and progression factors of hearing in sudden deafness. Braz J Otorhinolaryngol 2005;71:633-8
  4. Sano H, Okamoto M, Ohhashi K, Iwasaki S, Ogawa K. Quality of life reported by patients with idiopathic sudden sensorineural hearing loss. Otol Neurotol 2013;34:36-40
  5. Borton SA, Mauze E, Lieu JE. Quality of life in children with unilateral hearing loss: a pilot study. Am J Audiol 2010;19:61-72
  6. Rauch SD. Clinical practice. Idiopathic sudden sensorineural hearing loss. N Engl J Med 2008;359:833-40
  7. Enache R, Sarafoleanu C. Prognostic factors in sudden hearing loss. J Med Life 2008;1:343-7
  8. Eisenman D, Arts HA. Effectiveness of treatment for sudden sensorineural hearing loss. Arch Otolaryngol Head Neck Surg 2000;126:1161-4
  9. Kaya H, Koç AK, Sayın İ, Güneş S, Altıntaş A, Yeğin Y, et al. Vitamins A, C, and E and selenium in the treatment of idiopathic sudden sensorineural hearing loss. Eur Arch Otorhinolaryngol 2015;272:1119-25
  10. Wen YH, Chen PR, Wu HP. Prognostic factors of profound idiopathic sudden sensorineural hearing loss. Eur Arch Otorhinolaryngol 2014;271:1423-9
  11. Süslü N, Yilmaz T, Gürsel B. Utility of anti-HSP 70, TNFalpha, ESR, antinuclear antibody, and antiphospholipid antibodies in the diagnosis and treatment of sudden sensorineural hearing loss. Laryngoscope 2009;119:341-6
  12. Edgren G, Hjalgrim H, Rostgaard K, Norda R, Wikman A, Melbye M, et al. Risk of gastric cancer and peptic ulcers in relation to ABO blood type: a cohort study. Am J Epidemiol 2010;172:1280-5
  13. He M, Wolpin B, Rexrode K, Manson JE, Rimm E, Hu FB, et al. ABO blood group and risk of coronary heart disease in two prospective cohort studies. Arterioscler Thromb Vasc Biol 2012;32:2314-20
  14. Sanyelbhaa H, Kabel A, Abo El-Naga HAE, Sanyelbhaa A, Salem H. The risk ratio for development of hereditary sensorineural hearing loss in consanguineous marriage offspring. Int J Pediatr Otorhinolaryngol 2017;101:7-10
  15. Al Khabori M. Causes of severe to profound deafness in Omani paediatric population. Int J Pediatr Otorhinolaryngol 2004;68:1307-13
  16. Hong O. Hearing loss among